Based on our observations, we propose that the human‐specific C‐allele of ECR1 may induce higher levels of CB1 expression in the hippocampus in humans, thus protecting individuals from the anxiolytic and depression forming effects of stress following treatment with rimonabant (Akirav, 2011). Here, CNR1 is linked to depressive disorder.